Last Update 03 Mar 26

Fair value Decreased 5.47%

AZE: Margin Recovery And Dividend Visibility Will Support Future Upside Potential

Azelis Group’s analyst fair value estimate has been trimmed from €13.20 to about €12.48. This reflects a reset in price targets after some analysts reduced their outlooks toward the mid-teens and low double digits, while still factoring in updated views on growth, margins and future P/E levels.

Analyst Commentary

Recent street research on Azelis Group points to a mixed but engaged view on the shares, with target prices clustered in a band that still sits above the current trimmed fair value estimate of about €12.48. Analysts are fine tuning their expectations around execution, earnings visibility and what P/E levels feel appropriate.

Bullish Takeaways

Bullish analysts setting targets around €15 indicate that they still see room for upside versus the current fair value estimate, even after trimming earlier expectations.
The move to lift a target to €10.50 from €10 suggests some confidence that execution and earnings delivery can support at least a modestly higher valuation floor.
Higher targets in the low to mid teens suggest that some analysts are comfortable with Azelis trading on P/E multiples that assume solid, if not aggressive, growth and margin resilience.
Maintained positive ratings alongside reduced targets indicate a view that recent adjustments are more about recalibrating valuations rather than a fundamental shift in the long term equity story.

Bearish Takeaways

Target cuts from levels such as €17.50 down to €15 show that prior assumptions on earnings power or acceptable P/E levels are being reined in.
The existence of a €10.50 target highlights that some bearish analysts see limited upside and want more proof on growth consistency and margin execution before assigning higher valuations.
A recent downgrade reflects rising caution around near term delivery, with concerns that current expectations may still be too demanding if execution or market conditions disappoint.
The spread between targets in the low teens and mid teens underlines a valuation debate, with more cautious views focusing on potential pressure on returns if growth or margins do not track prior expectations.

What's in the News

The board has proposed a dividend of €0.226 per share for the year ended 31 December 2025, giving investors visibility on the next planned payout (Key Developments).
The proposed dividend timetable is set out in advance, with an ex dividend date on 27 June 2026, a record date on 30 June 2026, and a payment date on 1 July 2026 (Key Developments).
The forward dated schedule signals the board's current intentions for shareholder distributions linked to the 2025 financial year, subject to any future confirmations or approvals (Key Developments).

Valuation Changes

Fair value was trimmed from €13.20 to about €12.48, a reduction of roughly 5% that brings the central estimate closer to recent analyst target resets.
The discount rate was kept broadly steady at around 9.70%, with only a very small adjustment to 9.68% that signals minimal change in perceived risk assumptions.
Revenue growth was updated from about 1.64% to roughly 3.01%, indicating a higher expected top line trajectory in the current model, expressed in € terms.
The profit margin was nudged up from roughly 4.09% to about 4.16%, a modest change in assumed earnings efficiency on € revenue.
The future P/E eased from about 23.3x to roughly 21.4x, suggesting a slightly lower valuation multiple being used for Azelis Group in forward looking scenarios.

2 views

Key Takeaways

Strategic acquisitions and a strong M&A pipeline suggest future revenue growth and expanded net margins from realized synergies.
Investments in digitalization and sustainability could drive operational efficiencies, improving net margins and earnings stability long-term.
Geopolitical uncertainty, cost inflation, and regional inconsistencies could hinder Azelis Group's revenue growth and profitability, while working capital issues strain cash flow management.

Catalysts

About Azelis Group

Engages in the distribution of specialty chemicals and food ingredients.What are the underlying business or industry changes driving this perspective?

Azelis Group's organic growth turned positive in Q3 and Q4 of 2024, suggesting improving business conditions and momentum that could lift future revenue and earnings if the trend continues.
The company completed 8 acquisitions during 2024 with a strong focus on its strategic markets and indicated a promising M&A pipeline, which should contribute to future revenue growth and potentially expand net margins as synergies are realized.
Azelis is seeing a robust recovery in its Life Sciences segment, particularly in the U.S., which is one of its higher-margin areas, indicating potential for improved gross profit margins and earnings.
The company is investing in digitalization and sustainability initiatives, which could drive operational efficiencies and improve net margins over the long term.
Azelis' commitment to optimizing its product portfolio, especially in regions like Asia Pacific and Latin America, aligns with strategic focus, suggesting improved gross margins and earnings stability as higher-margin products are prioritized.

Azelis Group Earnings and Revenue Growth

Azelis Group Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Azelis Group's revenue will grow by 5.3% annually over the next 3 years.
Analysts assume that profit margins will increase from 4.0% today to 4.8% in 3 years time.
Analysts expect earnings to reach €238.0 million (and earnings per share of €0.96) by about September 2028, up from €169.4 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting €269.4 million in earnings, and the most bearish expecting €204.7 million.
In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 25.9x on those 2028 earnings, up from 17.7x today. This future PE is greater than the current PE for the BE Trade Distributors industry at 17.7x.
Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
To value all of this in today's terms, we will use a discount rate of 9.01%, as per the Simply Wall St company report.

Azelis Group Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?

The company is experiencing significant geopolitical uncertainty and market volatility, which may affect its ability to maintain stable revenue streams and profit margins.
Lingering cost inflation, including salary and logistics expenses, and higher distribution costs could potentially squeeze net margins, impacting overall profitability.
Although the company has shown positive organic growth, it continues to face inconsistent recovery across different regions, with certain areas like China and Australia remaining weak, which could hinder overall revenue growth.
The company's net profit remains flat, and leverage has increased to 2.9x, suggesting potential financial strain that could affect its ability to finance further growth or increase earnings.
Working capital challenges, particularly with higher inventory and receivables, are leading to lower free cash flow conversion, which may impact the company's ability to efficiently manage cash and meet financial obligations.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of €19.557 for Azelis Group based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €24.0, and the most bearish reporting a price target of just €16.0.
In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be €4.9 billion, earnings will come to €238.0 million, and it would be trading on a PE ratio of 25.9x, assuming you use a discount rate of 9.0%.
Given the current share price of €12.34, the analyst price target of €19.56 is 36.9% higher.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Azelis Group?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Recovery Will Likely Emerge After Industry Pressures Ease In 2026